The performance of Olainfarm Group in Q1 2021 is convincingly resilient

“We have started the year with a targeted momentum despite the impact of the Covid-19 pandemic, and this is also reflected in the company's financial results. The new marketing strategy was the driving force behind maintaining the position of our products and services in our markets. We are committed to our strategy and invest in production, product development, IT and digitalisation. Our care for patients with health problems related to pain, inflammation, cardiovascular disease, mental health and other conditions remains unchanged," said Jeroen Weites, Chairperson of the Management Board of JSC Olainfarm.

View post:
The performance of Olainfarm Group in Q1 2021 is convincingly resilient

Related Post